Jorge da Silva
Founder at MOONLAKE IMMUNOTHERAPEUTICS
Net worth: 134 M $ as of 2024-04-29
Network origin in Jorge da Silva first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 15 | |
Moonlake Immunotherapeutics AG
 Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
University of Minho
1
| College/University | Other Consumer Services | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jorge da Silva via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| VERNALIS | Pharmaceuticals: Major | Chief Executive Officer | |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| INAPA - INVESTIMENTOS, PARTICIPAÇÕES E GESTÃO, S.A. | Pulp & Paper | Director/Board Member | |
| University of Oxford | College/University | Doctorate Degree | |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
| Wake Forest University | College/University | Undergraduate Degree | |
| University of Cambridge | College/University | Graduate Degree | |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Corporate Officer/Principal | |
Dr. Reddy's Research & Development BV
 Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Dr. Reddy's Research & Development BV is engaged in the development and manufacture of injectable pharmaceutical products. It provides formulation, development, drug delivery, and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. The company was founded by Joost J. M. Holthuis on July 20, 1995 and is headquartered in Leiden, Netherlands. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal | |
| Yale University | College/University | Graduate Degree Corporate Officer/Principal | |
| The University of Colorado | College/University | Corporate Officer/Principal | |
| University of Bristol | College/University | Undergraduate Degree | |
| University of Leicester | College/University | Undergraduate Degree | |
| University of Gottingen | College/University | Doctorate Degree | |
| University of Hannover | College/University | Undergraduate Degree | |
| University of Groningen | College/University | Doctorate Degree Undergraduate Degree | |
Empresa Portuguesa das Aguas Livres SA
 Empresa Portuguesa das Aguas Livres SA Water UtilitiesUtilities Empresa Portuguesa das Aguas Livres SA engages in abstracting, producing, transporting and distributing water. The company was founded on April 2, 1868 and is headquartered in Lisbon, Portugal. | Water Utilities | Corporate Officer/Principal | |
| Autonomous University of Lisbon | College/University | Undergraduate Degree | |
The Broad Institute, Inc.
 The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Medical School | College/University | Corporate Officer/Principal | |
| Auto Jardim DO Algarve Automoveis de Aluguer SA | Director/Board Member | ||
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
Ordem dos Revisores Oficiais de Contas
 Ordem dos Revisores Oficiais de Contas Miscellaneous Commercial ServicesCommercial Services Ordem dos Revisores Oficiais de Contas provides accounting, technical support, and training services. The private company is based in Lisbon, Portugal. | Miscellaneous Commercial Services | Director/Board Member | |
| Columbia Business School | College/University | Masters Business Admin | |
Khondrion BV
 Khondrion BV Pharmaceuticals: MajorHealth Technology Khondrion BV is a Dutch clinical-stage biopharmaceutical company that focuses on discovering and developing therapies for mitochondrial diseases. The company is based in Nijmegen, Netherlands, and was founded in 2012 by Jan Smeitink, who has been the CEO since then. The company's lead drug candidate, sonlicromanol, is a first-in-class, oral small molecule that targets key underlying mechanisms of primary mitochondrial disease. The compound has been granted orphan drug designations for the treatment of various mitochondrial diseases. Khondrion collaborates with a clinical and academic network and patient organizations internationally to accelerate the discovery and development of its potential medicines. | Pharmaceuticals: Major | Chief Operating Officer | |
Expansion Therapeutics, Inc.
 Expansion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Expansion Therapeutics, Inc. manufactures pharmaceutical products. The company is headquartered in Del Mar, CA. | Pharmaceuticals: Major | Director/Board Member | |
Jnana Therapeutics, Inc.
 Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | Biotechnology | Founder | |
Cormorant Asset Management LLC/Private Equity/
 Cormorant Asset Management LLC/Private Equity/ Investment ManagersFinance Cormorant Asset Management LLC/Private Equity/ (Cormorant Asset Management) is a venture capital subsidiary of Cormorant Asset Management LP founded in 2013 by Bi Hua Chen. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
Celsius Therapeutics, Inc.
 Celsius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Celsius Therapeutics, Inc. translates single-cell genomic insights into precision therapeutics for autoimmune diseases and cancer. The company was founded by Jeffrey A. Bluestone, Vijay K. Kuchroo, Christoph S. Lengauer, Aviv Regev and Ramnik Xavier in 2018 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Founder | |
Kymab Group Ltd.
 Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
derma2go AG
 derma2go AG Internet Software/ServicesTechnology Services Derma2go AG operates an online platform for dermatological consultation. The company is based in Zurich, Switzerland. The Swiss company was founded in 2018 by Christian Greis and Vahid Djamei. Christian Greis has been the CEO since 2018. | Internet Software/Services | Director/Board Member | |
Enliven Therapeutics, Inc. /US/
 Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology EnLiven Therapeutics, Inc. engages in the discovery and development of small molecule treatments for cancer. The company was founded by Samuel S. Kintz and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
ONK Therapeutics Ltd.
 ONK Therapeutics Ltd. BiotechnologyHealth Technology ONK Therapeutics Ltd. develops bio cells for anti cancer therapies. The company was founded by Michael O'Dwyer and Anthony Killarney in 2015 and is headquartered in Galway, Ireland. | Biotechnology | Director/Board Member | |
Kestrel Therapeutics, Inc.
 Kestrel Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kestrel Therapeutics, Inc. is a company that has two habitat restoration projects aimed at helping native animals that are at risk, specifically the American Kestrel and the Eastern Spadefoot Toad. The company is based in Wayland, MA. The company's mission is to conserve and care for forests, farms, and riverways of the Pioneer Valley while nurturing an enduring love of the land. The CEO of the company is Frank G. Haluska. | Miscellaneous Commercial Services | Director/Board Member | |
Blossom Biosciences Ltd.
 Blossom Biosciences Ltd. BiotechnologyHealth Technology Blossom Biosciences Ltd. provides molecular and cell biology research services. The company is based in Hong Kong, Hong Kong. Andrew J. Phillips has been the CEO of the Chinese company since 2021. | Biotechnology | Chief Executive Officer | |
| JeruCON Beratungsgesellschaft mbH | Founder | ||
| Aleksia Therapeutics, Inc. | Chief Executive Officer | ||
| Blossom Biomedicines USA, Inc. | Director/Board Member | ||
| Moonlake Immunotherapeutics Ltd. | Director/Board Member Chief Tech/Sci/R&D Officer | ||
| ENLIVEN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| Godfrey Huggins School of Medicine | College/University | Undergraduate Degree | |
| Klarman Cell Observatory | Director/Board Member | ||
Nexo Therapeutics, Inc.
 Nexo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nexo Therapeutics is a small molecule oncology company that focuses on discovering and developing new drugs for cancer patients who do not have effective treatments. The company is based in Littleton, CO and Watertown, MA. The company uses covalent ligand discovery, chemical biology, cancer biology, and medicinal chemistry to target the underlying causes of cancer through innovative methods. Nexo Therapeutics was founded by John Athanosopoulos, Andrew J. Phillips, Michael Kim, and Rhamy Zeid. Andrew J. Phillips has been the CEO of the company since 2022. | Pharmaceuticals: Major | Founder | |
| Dermagnostix GmbH | Director/Board Member | ||
| Proderma Foundation | Director/Board Member |
Statistics
International
| United States | 23 |
| United Kingdom | 9 |
| Portugal | 6 |
| Germany | 6 |
| Switzerland | 4 |
Sectoral
| Health Technology | 18 |
| Consumer Services | 15 |
| Finance | 5 |
| Commercial Services | 4 |
| Process Industries | 2 |
Operational
| Director/Board Member | 64 |
| Corporate Officer/Principal | 33 |
| Independent Dir/Board Member | 22 |
| Undergraduate Degree | 12 |
| Chief Executive Officer | 11 |
Most connected contacts
- Stock Market
- Insiders
- Jorge da Silva
- Company connections
